The Effects of Inhaled Budesonide-formoterol-glycopyrronium in Moderate-to-severe COPD
Condition: Pulmonary Disease, Chronic Obstructive Interventions: Drug: BGF Inhalation Aerosphere; Drug: GFF Inhalation Aerosphere Sponsors: ShiYue Li; AstraZeneca Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials